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Abstract 
         Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that is characterized 
by abnormal social behavior, deficits in communication, and motor stereotypy. The SHANK3 
gene, responsible for the generation of a scaffolding protein that is integral for the development 
of synapses, has been identified as one of the primary candidate genes implicated in the disorder. 
Shank3B is the rodent homolog for this gene. Research has shown that when this gene is 
disrupted in rodent models (e.g., via knock-out (KO)), ASD-like behaviors result. These include 
deficits in social interaction, increased anxiety, and repetitive self-grooming. The current study 
aimed to identify a physiological marker for autism in Shank3B mutant mice. A neuroanatomical 
analysis of the volumes of the neocortex and amygdala, two of the primary brain structures 
implicated in ASD, was conducted in order to determine if a biomarker was present in the form 
of a volume difference in Shank3b KO mice. It was found that there was no significant volume 
difference between the gene knockout and control mice across both structures. However, the 
volume of the right cortex was found to be marginally decreased in the heterozygous mice 
compared to the control. This may be related to some of the memory deficits that are typical of 
ASD. Future research in this field should focus on analyzing some of the other brain structures 
that are functionally affected in the disorder, with the goal of finding a biological marker that 
may enable earlier diagnosis and intervention for ASD. 
Introduction 
         Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 1 in 54 
children (Maenner et al., 2020). The most common behavioral markers include deficits in social 
interaction, verbal and nonverbal communication, and stereotyped patterns of behavior (Amaral 
et al., 2008). The symptoms of autism are present from early childhood and affect daily 
functioning. Over the past few decades, the number of children diagnosed with autism has 
steadily increased, leading the emergence of ASD as a major public health concern in the United 
States (Kulage et al., 2014). However, it is unclear whether this increase is due to a higher 
incidence of children being affected or simply due to heightened awareness and broader 
diagnostic criteria. Prior to the publication of DSM-5 in 2013, three distinct autism spectrum 
disorders were defined: Autistic disorder, Asperger’s disorder, and Pervasive developmental 
disorder-not otherwise specified. However, in 2013 these were all combined into one broad 
diagnosis of Autism Spectrum Disorder (DSM-5). The term “spectrum” refers to the wide range 
of symptoms, skills, and difficulties that can occur in people with ASD depending on the severity 
of their diagnosis. It is crucial to identify the signs of ASD as soon as possible in a child’s life, 
and some symptoms may be present as early as toddlerhood. According to the National Institutes 
of Health, infants with ASD may become overly focused on certain objects, avoid eye contact, 
and fail to engage in babbling. In other cases, children may develop completely normally until 
two or three years of age, at which point symptoms begin to appear and they start to withdraw 
from social engagement (regression). Those children who display earlier signs are more likely to 
have a more severe and debilitating form of ASD, requiring support for their lifetime. In any 
case, indicative signs that a child may have ASD include social impairment, communication 
difficulties, and repetitive behaviors. 
         There is no singular known cause for ASD, but research has shown that both genetics and 
the environment play a role in pathogenesis. It is likely that ASD arises as a result of disruptions 
in brain growth very early in development. These disruptions in growth can be attributed to 
genes that are involved in the development of synapses and neuronal pruning, as well as 
environmental disturbances to growth such as premature birth. Families with a history of 
developmental disorders, mental retardation, or mental illness are at a higher risk of giving birth 
to a child with ASD. However, de novo gene mutations and copy number variants of 
chromosomes have been identified in some individuals with ASD, making it possible for two 
perfectly healthy parents to give birth to an autistic child. De novo copy number variants were 
found in 7% of individuals with idiopathic autism (Marshall et al., 2008). 
Although the exact neuropathology of ASD remains unknown, postmortem brain scans have 
identified the amygdala, frontal lobe, and cerebellum as pathological in autism (Amaral et al., 
2008).The amygdala theory of autism, as suggested by Baron-Cohen et al. (2000), suggests that 
atypical development of the amygdala results in the social intelligence deficits seen in 
individuals with ASD. In experiments involving primates, lesions in the amygdala resulted in 
failed social interactions, characterized by less initiation of social interactions and less 
responding to social gestures. The lesioned subjects became socially isolated and left their social 
group (Bickart et al., 2010). This study demonstrated that there is indeed a positive correlation 
between amygdala volume and social group size, which is one indicator of social intelligence. In 
an fMRI study by Baron-Cohen et al. (2000), subjects with and without autism were shown 
pictures of people with different facial expressions and told to judge the emotion of the person in 
the picture. Those with autism did not show amygdala activity during the task while those 
without autism did show amygdala activation. In a similar study by Howard et al. (2000), it was 
also found that people with high functioning autism display impairments characteristic of 
amygdala damage, such as the inability to accurately recognize facial expressions of fear as well 
as impairment in facial recognition memory. It is likely that these neuronal defects are a result of 
incomplete neuronal pruning during early brain development. Research by Schumann et al. 
(2004) further supported this idea of incomplete neuronal pruning by finding evidence that the 
amygdalas of children with autism (7.5-12.5 years of age) were enlarged compared to the 
control, but there was no difference in amygdala volume between adolescents with autism 
(12.75-18.5 years of age) and the control group. This suggests that individuals with autism 
display the opposite brain growth pattern of typically developing individuals, whose brains grow 
in size as they age. Rather, the amygdala in children with autism is initially larger, but it does not 
undergo the same age-dependent increase. 
         Many individuals with autism also exhibit poor fine and gross motor skills, pointing to 
possible dysfunction in the cerebellum. Several studies have found evidence of Purkinje cell 
death in the brains of autistic individuals postmortem (Fatemi et al., 2002). Cross sectional areas 
of Purkinje cells were found to be 24% smaller in  the brains of individuals with ASD when 
compared to brains of typical individuals. Additionally, deep cerebellar nuclei have been found 
to differ in size and number depending on the age of the individual affected. Autistic individuals 
over 21 possessed small, pale neurons significantly decreased in number compared to the 
control. However, autistic individuals aged 5-13 possessed large and plentiful neurons, very 
similar to unaffected people their age (Fatemi et al., 2012). This evidence points to the 
possibility that the etiopathogenesis of ASD is not just a prenatal process, but an ongoing 
postnatal process that occurs throughout one’s lifetime. A study by Allen and Courchesne (2003) 
found evidence pointing to the role the cerebellum plays in attention deficits in autism due to 
cerebellar projections to higher order brain structures. The cerebellum’s function in the 
pathology of ASD, not just with motor coordination but also with cognition, supports the fact 
that autism is a complex and multifaceted disorder. 
         Neuronal areas of the frontal lobe, particularly the prefrontal cortex, have also been found 
to be heavily implicated in ASD. The prefrontal cortex is involved in higher order emotional, 
social, and cognitive development. In a study by Courchesne et al. (2011), it was found that brain 
overgrowth in the prefrontal cortex during the early stages of development, as well as an excess 
of neurons, is characteristic of autism. In this study involving the analysis of postmortem brain 
tissue from autistic children aged 2 to 16 years, both the brain weight and neuron count was 
significantly increased compared to the control group. Additionally, a significant increase in 
microglial density in the dorsolateral prefrontal cortex has been identified in male autistic 
subjects (Morgan et al., 2010). They also identified an increase in microglial activation in the 
same brain areas via immunohistochemistry. This points to the possibility that microglial 
activation plays a key role in the pathogenesis of ASD, or alternatively that the activation may be 
representative of the brain’s innate immune response to synaptic and neuronal network 
disturbances. Not only does the structure of the prefrontal cortex affect behavior, but behavior 
also affects structure. In an experiment conducted by Liu et al. (2012) where mice were socially 
isolated for a long period of time, it was found that as a result, oligodendrocytes in their 
prefrontal cortex were degraded and myelination was impaired. However once these mice were 
reintegrated back into the social group, these transcriptional effects were reversed and their 
behavior returned back to normal.  It is evident that a clear age-dependent pattern has been found 
between the cortex and the pathophysiology of ASD. 
There is not one standard treatment for ASD, but current research is focused on 
identifying key genes implicated in the disorder using animal models. ASD is a complex disorder 
with various causes and multiple genes of interest. The SHANK3 gene has been identified as one 
of the most promising candidate genes for ASD. SHANK3 encodes scaffolding proteins that are 
integral for the postsynaptic density of excitatory synapses. It also plays a role in 
neurotransmitter receptors, ion channels, and dendritic spine maturation (Dhamne et al., 2017). 
Much of the current research is focused on the SHANK3B allelic mutant due to its more 
pronounced behavioral defects. It has been found that mice with deletions in the Shank3B gene 
exhibit ASD-like behaviors such as repetitive self-injurious grooming, anxiety, and deficits in 
social interaction. This was concluded through experiments in which it was shown that Shank3B 
knockout mice exhibit less rearing than WT in the open field test and less time in the open arms 
of elevated plus maze (Peca et al., 2011). The same study found that the Shank3B knockout mice 
preferred the empty cage and displayed less social novelty in the three chamber social task. 
Repetitive grooming behavior has also been reported in Shank3B mice, suggesting alterations in 
cortico-striatal functionality, as reported by Peca et al. (2011). Another study conducted by 
Rendall et al. (2018) observed atypical social behavior in Shank3B mutants, through increased 
dominance in the social dominance tube task. Although these results are typical of social 
aggression, this study concluded that they may reflect failure to properly process social cues 
when confronted when another mouse. These mice have decreased levels of scaffolding proteins 
and glutamate receptors in the striatum, providing overwhelming support for the connection 
between a disruption in the Shank3B gene and the development of ASD-like behaviors in mice 
(Balaan et al., 2019). 
         The current experiment sought to contribute to the current body of knowledge by 
identifying a physiological marker of ASD that may be used to screen toddlers, allowing for 
earlier detection and diagnosis. According to the National Institutes of Health, early diagnosis 
and intervention for autism can have immense positive effects on the individual’s skills later on 
in life. The only treatment currently available for ASD involves a combination of therapies; 
speech therapy, cognitive behavioral therapy, behavioral management therapy, social skills 
training, and physical therapy to name a few. Currently, the average age for ASD diagnosis in 
the United States is just over four years of age (Maenner et al., 2020). However, depending on 
the severity of the disorder, it can be possible to diagnose some children before they turn two. 
Early interventions prior to the preschool age, while a child’s brain is still very much plastic, 
allow treatment to be more effective throughout the individual’s life. Early intervention has the 
ability to greatly improve an individual's behavioral outcome. The primary goal of this 
experiment was to identify a biomarker for ASD, such as brain volume, that can allow medical 
professionals to help diagnose children with autism as early as possible. Oftentimes children who 
display some of the less severe behavioral signs are misdiagnosed. Furthermore, many children 
do not display any symptoms until the age of four – at this age, improved outcomes through 
behavioral intervention can be negatively impacted . However, if a significant difference in 
neuronal volume can be identified in children with autism when compared with their peers of the 
same age, an ASD diagnosis can be made before atypical behaviors are noticed and intervention 
can be made available earlier than before. 
         The use of a mouse model was necessary for this study. Mutations in the SHANK3B gene 
are implicated in ASD in humans. When the Shank3B gene is targeted for disruption in mice, the 
rodent homolog of SHANK3B, they exhibit ASD-like behaviors such as self-injurious stereotypy, 
increased anxiety, and social deficits. The current study focuses on the neuroanatomical analysis 
of the structural volume of the neocortex and amygdala —  two of the main brain structures 
implicated in ASD. Due to prior research that has been collected, it is evident that the amygdala 
is involved in social interaction and facial/emotional recognition, while the cortex is involved in 
higher order cognition and goal-directed behavior. An age-dependent pattern of reverse growth 
in autistic brains has been found for both the cortex and amygdala. While typically developing 
individuals start out with a smaller brain volume which then increases as they age, autistic 
individuals seem to have the opposite pattern of growth. They are born with an excess 
overgrowth in brain tissue compared to controls, and these differences level out after the 
adolescent years. Therefore, it was predicted that an increase in structural volume of both the 
amygdala and cortex would be observed in Shank3B knockout mice compared to heterozygous 
and wildtype. 
Methods 
Subjects 
         Heterozygous breeding pairs of B6.129‐Shank3tm2Gfng mutant mice were purchased from 
The Jackson Laboratory (Bar Harbor, Maine). In this strain, exons 13-16 of the Shank3 gene, 
which encodes the PDZ domain, were replaced with a neo cassette. This resulted in the absence 
of Shank3α and Shank3β isoform expression, and a reduction in the Shank3γ isoform (Peca et 
al., 2011). Subjects for this experiment were generated from Het x Het breeding at the University 
of Connecticut. Genotypes of the offspring were determined by mouse ear punch DNA, using the 
following PCR primers: Common (GAGACTGATCAGCGCAGTTG), Wild Type Reverse 
(TGACATAATCGCTGGCAAAG), and Mutant Reverse 
(GCTATACGAAGTTATGTCGACTAGG) (Rendall et al., 2018). 22 male subjects were chosen 
for this study through behavioral phenotyping and histological assessment. Of the total subjects, 
7 were Wildtype (WT), 9 were Heterozygous (HT), and 6 were Shank3B knockouts (KO). 
Following breeding, all subjects were individually housed in standard mouse tubs, in 12 hour 
light/dark cycles with food and water available ad libitum. Data collection was carried out blind 
to genotype. All procedures were conducted in compliance with the National Institutes of Health 
and the University of Connecticut’s Institutional Animal Care and Use Committee. 
Brain Slicing and Nissl Staining 
         Following behavioral testing (see Rendall et al., (2019) for the behavioral 
characterization of Shank3B KO mice), the adult mice were prepared to be euthanized at P200. 
The subjects were weighed and anesthetized with 100/15 mg/kg ketamine/xylazine. They were 
transcardially perfused with 0.9% saline and 10% formalin. Their brains were individually 
extracted and fixed in 10% formalin. The brains were serially sectioned on the coronal plane 
using a vibratome (Leica; VT 1000S). Sections were sliced 60 μm thick. Rather than mounting 
every section, every second section was mounted on gelatin-subbed slides. Nissl bodies were 
stained using cresyl violet. 
Stereological Measures 
         All prepared brain slices were analyzed using Stereo Investigator (MBF Biosciences, 
Williston, VT, USA) in conjunction with a Zeiss Axio Imager A2 Microscope (Karl Zeiss, 
Thornwood, NY). The volumes of the cortex and amygdala of each subject were measured using 
the Cavalieri Estimator probe in Stereo Investigator. For the cortex, every fourth mounted slice 
was traced, accounting for every eighth brain section, since every other section was mounted. 
Tracing started at the very first mounted slice. About 8-10 sections per brain were traced for 
cortex analysis. Total number of sections differed by subject depending on total brain volume. 
For the amygdala, every mounted slice was traced, accounting for every other brain section. 
Rather than beginning at the very first mounted slice, tracing began around the eighth slice, since 
the amygdala is localized medially in the brain. Ten sections per brain were traced for amygdala 
analysis. Contours for volumetric measurements were drawn at 2.5x magnification, and a 
standard stereotaxic atlas was utilized to help determine the anatomical location of the cortex and 
amygdala. 
Results 
Data analysis was run using IBM SPSS Statistics, using a (one-way?) ANOVA test to 
determine if Genotype had a significant effect on the structural volumes of the cortex and 
amygdala. Results showed that there was no significant difference among the right amygdala, 
left amygdala, or total amygdala volume across all three genotypes (WT, HT, and KO). These 
results can be seen in Figure 1 (p>0.05). Preliminary analysis also found that there was no 
significant difference among the right cortex, left cortex, or total cortex volume across all three 
genotypes (p>0.05). However, recognizing that the right cortex volume of the HT treatment 
group seemed prominently less than that of the WT and KO groups (as seen in Figure 2), a 
repeated ANOVA was performed to compare the cortex volume of the HT subjects to the control 
group. Only the HT and WT treatment groups were included in this ANOVA, and the results can 
be seen in Figure 3. This statistical analysis revealed that the volume of the right cortex was 
marginally decreased in the HT mice compared to the WT mice [F(1,15)=3.274, p<0.10]. 
 
Figure 1. Comparison of amygdala volume across all genotypes. No significant difference was found. 
 
 
Figure 2. Comparison of cortex volume across all genotypes. No significant difference was found. 
  
Figure 3. Comparison of cortex volume between WT and HT groups. The right cortex was found to be marginally 
significantly decreased in HT subjects compared to control (p<0.10). The average right cortex volume of WT was 
34.32 mm3, with a SEM of 2.24 mm3, and the average right cortex volume of HT was 28.84 mm3, with a SEM 2.02 
mm3. 
Discussion 
         The lack of significance in the volumes of the cortex and amygdala between the Shank3B 
KO mice and WT mice may indicate something important. Despite the substantial dysfunctions 
in the neural networks and synapses of these brain areas, the total structural volume is not 
significantly different. From these data, it can be concluded that ASD is a disorder of neural 
abnormalities, as opposed to a disorder in which brain structures are diminished, as is common in 
many other neurodevelopmental disorders. Physiological differences in the neuroanatomy of 
these structures may be seen at a molecular level, or even at the level of a single cell. Replicating 
this study using live animals and functional imaging may help illuminate some of the cellular-
level differences in circuitry. However, at the gross level of the brain as a whole there was no 
statistical difference in the volume of the cortex and amygdala. 
         The data show a trend towards a larger amygdala volume in the HT and KO mice 
compared to the WT control. This seems to support the prior research and hypothesis. This trend 
may be indicative of the brain overgrowth that is characteristic of children with autism, 
according to human research that has been conducted. It is possible that if this study were 
repeated with mice of a younger age, or with a larger sample size, that a more significant 
increase in volume may be discovered. 
         The marginal significance (0.05<p<0.10) in the right cortex volume of the HT mice 
compared to WT mice presents novel information. The right cortex may play a significant role in 
the pathology of ASD. Compared to the left cortex, where a significant difference between 
volume was not found, the volume of the right cortex was marginally reduced in HT mice 
compared to WT. This warrants investigation into the distinct functions of the right and left 
cortex, and how these may play a role in the disorder. The left cortex, specifically the left inferior 
prefrontal cortex, mediates semantic memory and retrieval as seen in neuroimaging studies 
(Wagner et al., 2001). Another study conducted by Badre & Wagner (2007) implicates the left 
ventrolateral prefrontal cortex in the cognitive control of semantic memory, in which memory is 
strategically accessed when it is relevant to current goals and actions. Based on substantial 
research, there is a clear connection between the left cortex and semantic memory. 
         The right cortex on the other hand, has been found to play a more distinct role in episodic 
memory. Research by Kennan et al. (2000) utilizing neuroimaging technology and split-brain 
individuals has found a link between the right frontotemporal prefrontal cortex and 
autobiographical memory. It appears that there is a self-recognition center localized in the right 
prefrontal cortex that is important in self evaluation and autobiographical retrieval. Additional 
studies have also found that the right anterior prefrontal cortex is activated during episodic 
memory retrieval tasks (Allan et al., 2000). In autobiographical memory studies with autistic 
individuals, it has been found that adults with ASD demonstrate an episodic memory deficit, 
while their semantic memory remains intact (Crane & Goddard, 2007). This may explain why 
anatomical analysis revealed a marginally significant decrease in the right cortex volume of HT 
subjects, but no such volume reduction was found in the left cortex. 
These findings are likely related to the memory split that is characteristic of ASD. 
Episodic memory is composed of previous experiences and events in the context of their 
associated emotions. By contrast, semantic memory is related to information about oneself or 
others, such as words, concepts, and numbers. While semantic memory remains intact in 
individuals with ASD, episodic memory is negatively affected. The behavioral effects of this can 
be seen in studies such as those conducted by Baron-Cohen et al. (2000) and Howard et al. 
(2000), where autistic individuals failed to recognize emotion and demonstrated deficits in facial 
recognition memory, components of episodic memory. Further evidence supporting the right 
hemisphere laterality of emotional facial recognition can be seen in research by Suberi and 
McKeever (1977). They tested phenotypically normal females on how quickly they were able to 
discriminate familiar faces from non-familiar faces. Faster reaction times were obtained for 
images shown in the left visual field, compared to images shown in the right visual field. This 
supports right hemisphere superiority in facial recognition, an ability that is impaired in autistic 
individuals. 
         The right cortex also plays a key role in response inhibition, which is the suppression of 
actions that are inappropriate in a given context or that interfere with goal-driven behavior 
(Mostofsky & Simmonds, 2008). Human lesion-mapping supports the localization of the 
executive control of inhibition to the right inferior frontal cortex (Aron et al., 2004). In response 
inhibition tasks involving autistic individuals, it has been found that compared to the control, 
they have less brain activation in the neural areas involved in the inhibition network, but more 
brain activation in premotor brain areas (Kana et al., 2007). These results indicate that the 
response inhibition circuitry is atypical in the brains of autistic individuals, and postulate an 
additional explanation for the abnormal volume reduction of the right cortex that was seen in this 
study. 
         Ultimately these findings in the Shank3B mutant mouse model of autism may not be 
perfectly generalizable to Autism Spectrum Disorder in humans. Though there has been a 
multitude of scientific evidence connecting the phenotypic behavior of Shank3B knockouts to 
autism-like behavior displayed in affected humans, there has yet to be unequivocal research on 
the physiological and anatomical similarities between the two species. While the SHANK3 gene 
is one of the major genes implicated in the majority of ASD cases, autism in humans is a 
polygenic disorder. For this reason we cannot offer definitive conclusions, but further research 
into the neuroanatomical analysis of ASD is encouraged. 
Future Directions 
         Confirmation and clarification of the results from this experiment would require a larger 
sample size as well as multiple experimenters to control for the inconsistency and human error 
that may arise from having a single experimenter conduct tracing. Future research geared toward 
accomplishing the goal of this experiment, which was to identify a clear physiological marker for 
Autism Spectrum Disorder, should focus on studying other brain structures that are implicated in 
the disorder. Such structures include the cerebellum and white matter tracts. Plentiful research 
has found evidence to support the role of the cerebellum in the pathology of ASD (Fatemi et al., 
2002; Fatemi et al., 2012; Allen & Courchesne, 2003). There have also been studies that 
identified an increase in the volume of white matter tracts in certain areas of the brain. Herbert et 
al. (2004) found that all white matter tracts in the outer radiate zone of the brain had been 
enlarged in the brains of individuals with high-functioning autism. Several studies have 
implicated that the enlargement and decrement of the structural integrity of white matter tracts 
persist into adulthood, demonstrating that the pathology of ASD is an ongoing postnatal process 
(Herbert et al., 2004; Keller et al., 2007). Furthermore, the lack of significant results from this 
study may be due to the age at which the mice were sacrificed. Adult mice were used in this 
study, however given the age dependent effects of volume seen in humans, it may be helpful to 
use younger mice when replicating this study. It would be seminal to take this research one step 
further and investigate if there is a biomarker of ASD present at birth, or from a very early age, 
in order to help enable earlier diagnosis and intervention for autism. 
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